152 related articles for article (PubMed ID: 2902199)
1. Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.
Whitford C; Candy J; Edwardson J; Perry R
J Neurol Sci; 1988 Aug; 86(1):13-8. PubMed ID: 2902199
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes.
Beal MF; Mazurek MF; Martin JB
Brain Res; 1986 Nov; 397(2):386-8. PubMed ID: 3801878
[TBL] [Abstract][Full Text] [Related]
3. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Tran VT; Chattha G; Bird ED; Martin JB
Science; 1985 Jul; 229(4710):289-91. PubMed ID: 2861661
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin and neuropeptide Y immunoreactivity in Parkinson's disease dementia with Alzheimer's changes.
Beal MF; Clevens RA; Mazurek MF
Synapse; 1988; 2(4):463-7. PubMed ID: 2903567
[TBL] [Abstract][Full Text] [Related]
5. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
[TBL] [Abstract][Full Text] [Related]
6. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study.
Whitehouse PJ; Martino AM; Wagster MV; Price DL; Mayeux R; Atack JR; Kellar KJ
Neurology; 1988 May; 38(5):720-3. PubMed ID: 3362368
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin-28(1-12)-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex.
Beal MF; Benoit R; Mazurek MF; Bird ED; Martin JB
Brain Res; 1986 Mar; 368(2):380-3. PubMed ID: 2870772
[TBL] [Abstract][Full Text] [Related]
8. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele.
Grouselle D; Winsky-Sommerer R; David JP; Delacourte A; Dournaud P; Epelbaum J
Neurosci Lett; 1998 Oct; 255(1):21-4. PubMed ID: 9839717
[TBL] [Abstract][Full Text] [Related]
9. Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal cortices in Alzheimer's disease.
Krantic S; Robitaille Y; Quirion R
Brain Res; 1992 Feb; 573(2):299-304. PubMed ID: 1354549
[TBL] [Abstract][Full Text] [Related]
10. Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease.
Reinikainen KJ; Riekkinen PJ; Jolkkonen J; Kosma VM; Soininen H
Brain Res; 1987 Jan; 402(1):103-8. PubMed ID: 3828777
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism.
Tamminga CA; Foster NL; Fedio P; Bird ED; Chase TN
Neurology; 1987 Jan; 37(1):161-5. PubMed ID: 2879258
[TBL] [Abstract][Full Text] [Related]
12. CSF somatostatin-like immunoreactivity in dementia.
Beal MF; Growdon JH; Mazurek MF; Martin JB
Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
[TBL] [Abstract][Full Text] [Related]
13. A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease.
Davies CA; Morroll DR; Prinja D; Mann DM; Gibbs A
J Neurol Sci; 1990 Apr; 96(1):59-73. PubMed ID: 1972185
[TBL] [Abstract][Full Text] [Related]
14. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
Davies P; Terry RD
Neurobiol Aging; 1981; 2(1):9-14. PubMed ID: 6115327
[TBL] [Abstract][Full Text] [Related]
15. Galanin-like immunoreactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease.
Gabriel SM; Bierer LM; Davidson M; Purohit DP; Perl DP; Harotunian V
J Neurochem; 1994 Apr; 62(4):1516-23. PubMed ID: 7510783
[TBL] [Abstract][Full Text] [Related]
16. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
Davies P; Katzman R; Terry RD
Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862
[TBL] [Abstract][Full Text] [Related]
17. Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex.
Gabriel SM; Bierer LM; Harotunian V; Purohit DP; Perl DP; Davis KL
Neurosci Lett; 1993 May; 155(1):116-20. PubMed ID: 8103205
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease.
Candy JM; Gascoigne AD; Biggins JA; Smith AI; Perry RH; Perry EK; McDermott JR; Edwardson JA
J Neurol Sci; 1985 Dec; 71(2-3):315-23. PubMed ID: 2868073
[TBL] [Abstract][Full Text] [Related]
19. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
Perry RH; Perry EK; Smith CJ; Xuereb JH; Irving D; Whitford CA; Candy JM; Cross AJ
J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
[TBL] [Abstract][Full Text] [Related]
20. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
Reinikainen KJ; Soininen H; Riekkinen PJ
J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
